9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation between CVRF and the clinical characteristics of patients with HCM enrolled in the EURObservational Research Programme (EORP) Cardiomyopathy registry.

          Methods and results

          1739 patients with HCM were studied. The relation between hypertension (HT), diabetes (DM), body mass index (BMI), and clinical traits was analysed. Analyses were stratified according to the presence or absence of a pathogenic variant in a sarcomere gene. The prevalence of HT, DM, and obesity (Ob) was 37, 10, and 21%, respectively. HT, DM, and Ob were associated with older age ( P<0.001), less family history of HCM (HT and DM P<0.001), higher New York Heart Association (NYHA) class ( P<0.001), atrial fibrillation (HT and DM P<0.001; Ob p = 0.03) and LV (left ventricular) diastolic dysfunction (HT and Ob P<0.001; DM P = 0.003). Stroke was more frequent in HT ( P<0.001) and mutation-positive patients with DM ( P = 0.02). HT and Ob were associated with higher provocable LV outflow tract gradients (HT P<0.001, Ob P = 0.036). LV hypertrophy was more severe in Ob ( P = 0.018). HT and Ob were independently associated with NYHA class (OR 1.419, P = 0.017 and OR 1.584, P = 0.004, respectively). Other associations, including a higher proportion of females in HT and of systolic dysfunction in HT and Ob, were observed only in mutation-positive patients.

          Conclusion

          Common CVRF are associated with a more severe HCM phenotype, suggesting a proactive management of CVRF should be promoted. An interaction between genotype and CVRF was observed for some traits.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: found

          2018 ESC/ESH Guidelines for the management of arterial hypertension

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

                Bookmark

                Author and article information

                Contributors
                Journal
                Eur Heart J Qual Care Clin Outcomes
                Eur Heart J Qual Care Clin Outcomes
                ehjqcco
                European Heart Journal. Quality of Care & Clinical Outcomes
                Oxford University Press
                2058-5225
                2058-1742
                January 2023
                09 February 2022
                09 February 2022
                : 9
                : 1
                : 42-53
                Affiliations
                Serviço de Cardiologia, Hospital Garcia de Orta , Av. Torrado da Silva, Almada 2805-267, Portugal
                Institute of Cardiovascular Science, University College London , Gower St, London WC1E 6BT, UK
                St. Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust , Whitechapel Rd, London E1 1BB, UK
                Department of Advanced Biomedical Sciences, University Federico II , Corso Umberto I, 40, Naples 80138, Italy
                Department of Cardiology and Division of Cardiovascular Sciences, Guy's and St. Thomas’ Hospitals and King's College London , Strand, London WC2R 2LS, UK
                EORP, European Society of Cardiology , Sophia-Antipolis, France
                APHP, Centre de Référence des Maladies Cardiaques Héréditaires, Assistance Publique-Hôpitaux de Paris, ICAN, Hôpital Pitié-Salpêtrière, 47-83 Bd de l'Hôpital , Paris 75013, France
                Sorbonne Université, Inserm UMR1166, 15-21 Rue de l'École de Médecine , Paris 75006, France
                Hospital Clínico Universitario Virgen de la Arrixaca , Ctra. Madrid-Cartagena, Murcia 30120 El, Spain
                Institute of Cardiovascular Science, University College London , Gower St, London WC1E 6BT, UK
                Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital , London WC1N 3JH, UK
                EORP, European Society of Cardiology , Sophia-Antipolis, France
                Maria Cecilia Hospital , GVM Care&Research, Via Corriera, 1, Cotignola 48033 RA, Italy
                Maria Cecilia Hospital , GVM Care&Research, Via Corriera, 1, Cotignola 48033 RA, Italy
                Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo , Viale Camillo Golgi, Pavia 27100, Italy
                Serviço de Cardiologia, Centro Hospitalar Universitário Lisboa Norte , Lisbon 1169-050, Portugal
                CCUL, Faculdade de Medicina, Universidade de Lisboa , Av. Prof. Egas Moniz MB, Lisbon 1649-028, Portugal
                Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University , Universiteto g. 3, Vilnius 01513, Lithuania
                State Research Institute Centre for Innovative Medicine , Vilnius, Lithuania
                Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Département de Cardiologie, Paris, France & Université Paris Descartes, Sorbonne Paris Cité , Paris 75006, France
                2nd Department of Internal Cardiovascular Medicine, General University Hospital and First Medical Faculty, Charles University , Opletalova 38, Prague 110 00, Czech Republic
                Department of Cardiology, Odense University Hospital , J. B. Winsløws Vej 4, Odense 5000, Denmark
                Unidad de Insuficiencia Cardiaca y Cardiopatías Familiares. Servicio de Cardiología. Hospital Universitario Virgen de la Victoria. IBIMA. Málaga and Ciber-Cardiovascular. Instituto de Salud Carlos III. Madrid , Spain
                Inherited Cardiovascular Disease Unit Son Llatzer University Hospital & IdISBa , Palma de Mallorca, Spain
                Universitätsklinikum Würzburg, Deutsches Zentrum für Herzinsuffizienz (DZHI) , Comprehensive Heart Failure Center (CHFC), Am Schwarzenberg 15, Haus 15A, 97078 Wurzburg, Germany
                Member of National Centers of expertise for familial cardiopathies (CSUR), Cardiology Department, University Hospital of Salamanca. Institute of Biomedical Research of Salamanca (IBSAL) , CIBERCV, Salamanca, Spain
                Cardiology, Department of Cardiological, Thoracic and Vascular Sciences and Public Health, University of Padova , Via VIII Febbraio, 2, Padova 35122, Italy
                Institute of Cardiovascular Science, University College London , Gower St, London WC1E 6BT, UK
                St. Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust , Whitechapel Rd, London E1 1BB, UK
                Author notes
                Corresponding author. Tel: +447765109343, Email: luis.lopes.10@ 123456ucl.ac.uk , Twitter handle: @LuisRLopesDr

                Members of the European Reference Network on Heart diseases (ERN GUARD-HEART)

                Author information
                https://orcid.org/0000-0002-6408-4667
                https://orcid.org/0000-0002-1782-1118
                https://orcid.org/0000-0003-2764-6779
                https://orcid.org/0000-0003-2948-7994
                https://orcid.org/0000-0003-4685-6077
                https://orcid.org/0000-0002-3372-7850
                https://orcid.org/0000-0002-4901-5655
                Article
                qcac006
                10.1093/ehjqcco/qcac006
                9745665
                35138368
                a3c729f6-ead0-4876-bce5-6fd5959594ca
                © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 04 January 2022
                : 02 February 2022
                : 04 February 2022
                : 05 May 2022
                Page count
                Pages: 12
                Funding
                Funded by: Abbott Vascular, DOI 10.13039/100011949;
                Award ID: 2011-2021
                Funded by: Amgen Foundation, DOI 10.13039/100000042;
                Award ID: 2009-2018
                Funded by: AstraZeneca, DOI 10.13039/100004325;
                Award ID: 2014-2021
                Funded by: Bayer AG, DOI 10.13039/100004326;
                Award ID: 2009-2018
                Funded by: Boehringer Ingelheim, DOI 10.13039/100001003;
                Award ID: 2009-2019
                Funded by: Boston Scientific, DOI 10.13039/100008497;
                Award ID: 2009-2012
                Funded by: Bristol Myers Squibb, DOI 10.13039/100008021;
                Funded by: Pfizer, DOI 10.13039/100004319;
                Award ID: 2011-2019
                Funded by: Daiichi Sankyo Europe GmbH, DOI 10.13039/501100022274;
                Award ID: 2011-2020
                Funded by: Alliance Daiichi Sankyo Europe GmbH;
                Funded by: Eli Lilly and Company, DOI 10.13039/100004312;
                Award ID: 2014-2017
                Funded by: Edwards, DOI 10.13039/100006520;
                Award ID: 2016-2019
                Funded by: Gedeon Richter, DOI 10.13039/501100003358;
                Award ID: 2014-2016
                Funded by: Menarini Int. Op.;
                Award ID: 2009-2012
                Funded by: MSD-Merck & Co.;
                Award ID: 2011-2014
                Funded by: Novartis Pharma, DOI 10.13039/100008792;
                Award ID: 2014-2020
                Funded by: ResMed Foundation, DOI 10.13039/100003305;
                Award ID: 2014-2016
                Funded by: Sanofi, DOI 10.13039/100004339;
                Award ID: 2009-2011
                Funded by: Servier, DOI 10.13039/501100011725;
                Award ID: 2009-2021
                Funded by: Vifor Pharma, DOI 10.13039/501100006484;
                Award ID: 2019-2022
                Funded by: Medical Research Council, DOI 10.13039/501100000265;
                Funded by: British Heart Foundation, DOI 10.13039/501100000274;
                Funded by: GOSH, DOI 10.13039/501100001279;
                Funded by: NIHR, DOI 10.13039/100006662;
                Funded by: BRC, DOI 10.13039/100014461;
                Categories
                Original Article
                AcademicSubjects/MED00200

                cardiovascular risk factors,hypertension,diabetes,obesity,hypertrophic cardiomyopathy,genotype

                Comments

                Comment on this article